cortair 0,5 mg/1 ml suspenzija za raspršivanje
tuzlafarm d.o.o. tuzla - будесонид - suspenzija za raspršivanje - 0,5 mg/1 ml - 1 ml suspenzije za raspršivanje sadrži 0,5 mg budesonida
cortair 0,25 mg/1 ml suspenzija za raspršivanje
tuzlafarm d.o.o. tuzla - будесонид - suspenzija za raspršivanje - 0,25 mg/1 ml - 1 ml suspenzije za raspršivanje sadrži 0,25 mg budesonida
labazenit
laboratoires smb s.a. - budesonide, salmeterol - astma - treatment of asthma.
budosan 9 mg želučanootporne granule
dr. falk pharma gmbh, leinenweberstraße 5, freiburg, njemačka - budesonidum - želučanootporne granule - 9 mg - urbroj: svaka vrećica sadrži 9 mg budezonida
symbicort turbuhaler 4.5mcg + 160mcg prašak za inhalaciju
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - formoterol, budesonid - prašak za inhalaciju - 4.5mcg + 160mcg
airbufo forspiro 4.5mcg/doza + 160mcg/doza prašak za inhalaciju, podijeljen
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - formoterol, budesonid - prašak za inhalaciju, podijeljen - 4.5mcg/doza + 160mcg/doza
budekort 1 mg/2 ml suspenzija za raspršivanje
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - будесонид - suspenzija za raspršivanje - 1 mg/2 ml - jedna ampula od 2 ml sadrži 1 mg budesonida.
duoresp spiromax 320 µg/1 doza+ 9 µg/1 doza prašak inhalata
pliva d.o.o.sarajevo - будесонид, formoterol - prašak inhalata - 320 µg/1 doza+ 9 µg/1 doza - 1 doza sadrži: 320 mikrograma budesonida 9 mikrograma formoterol fumarat dihidrata
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).
duoresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - lijekovi za opstruktivne plućne bolesti dišnih putova, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).